Products

SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.

See all 1 product →

About SafeBeat Rx

SafeBeat Rx is a healthcare AI company focused on transforming cardiac care by expanding access to remote patient monitoring (RPM), continuous telemetry, event monitoring, and software-enabled remote therapeutic monitoring (RTM). The company’s core offering is an integrated technology that utilizes automated artificial intelligence-based software to analyze electrocardiogram (ECG) data. This technology is designed to replace the traditional three-day hospitalization often required for cardiac monitoring when initiating certain antiarrhythmic medications, enabling arrhythmia patients to start these medications safely from home.

For physicians, SafeBeat Rx’s platform aims to streamline clinical workflows and enhance patient monitoring by providing explainable AI and custom tools that display diagnostic information and treatment steps tailored to the patient. The company’s proprietary machine learning algorithms are designed for ECG interpretation and treatment management recommendations, offering efficiency and streamlined insights. SafeBeat Rx’s technology is currently under development and limited to investigational use, with ongoing clinical trials, including one at the University of California, San Francisco (UCSF), to validate its algorithms and gather user feedback.

Focus Areas

cardiac care remote patient monitoring remote therapeutic monitoring ECG analysis artificial intelligence atrial fibrillation drug-induced QT prolongation digital health wearables

Business Intelligence

Technologycloud-native, AI-based software platform with proprietary machine learning algorithms for ECG interpretation and treatment management, integrated with third-party FDA-cleared cardiac monitoring devices (mobile ECG, mobile cardiac telemetry, implantable cardiac monitor)

What Physicians Need to Know

Specialization in Cardiac Care
SafeBeat Rx focuses on cardiac care, particularly in managing atrial fibrillation (AFib) and drug-induced QT prolongation. They aim to expand access to life-saving heart medications by enabling safe, at-home monitoring and drug dosing guidance.
Remote Patient Monitoring (RPM) & Remote Therapeutic Monitoring (RTM)
The company provides integrated technology for remote patient monitoring, event monitoring, software-enabled remote therapeutic monitoring, and cardiac implantable electronic device monitoring. Their platform allows for remote monitoring of patients starting and continuing medications for atrial fibrillation, all from a mobile phone.
Advanced ECG Analysis
SafeBeat Rx utilizes an AI-powered ECG platform that offers beat-by-beat ECG analysis, providing full transparency and the option to adjust measurements for each individual heartbeat. This specialized ECG analysis powers their platform to expand access to remote therapeutic monitoring using third-party FDA-cleared cardiac monitoring devices.
Artificial Intelligence & Machine Learning
Proprietary machine learning algorithms are at the core of SafeBeat Rx's solutions, powering ECG interpretation and treatment management recommendations. Their AI-based ECG analysis software has been validated against expert cardiologist adjudication.
Atrial Fibrillation Management
SafeBeat Rx is developing a medical software solution for safe, at-home ECG monitoring and drug dosing guidance for AFib patients. Their technology aims to replace traditional inpatient hospital stays required for drug initiation and monitoring, allowing patients to manage their heart rhythm disorders remotely.
Drug-Induced QT Prolongation
SafeBeat Rx addresses the critical safety concern of drug-induced QT prolongation, which is a leading cause of FDA nonapproval for many medications. Their AI-powered ECG platform provides accurate QT interval measurements, which is essential for detecting prolonged QT and preventing life-threatening arrhythmias.
Digital Health & Wearables
The platform unlocks the full capabilities of digital health and remote care, utilizing FDA-cleared wearable ECG hardware and integrating with mobile ECG, mobile cardiac telemetry, and implantable cardiac monitors.
Physician Tip

SafeBeat Rx offers physicians a streamlined mobile-first platform with explainable AI and custom tools that display diagnostic information and patient-specific treatment steps, reducing alert fatigue. The technology aims to improve post-discharge cardiac surveillance and provides a novel approach to guideline-adherent pharmacological disease management. It enables safe, at-home initiation and titration of antiarrhythmic drugs, potentially reducing the need for costly and anxiety-inducing inpatient hospital stays. The platform's high QTc accuracy (5u00b17 ms) and 90% accuracy in recommending AAD dosing compared to physicians can enhance clinical decision-making and expand access to life-saving medications, especially for underserved populations.

SafeBeat Rx's specialized ECG analysis powers its platform to expand access to remote therapeutic monitoring using third-party FDA-cleared cardiac monitoring devices, including mobile ECG, mobile cardiac telemetry, and implantable cardiac monitors. The company is also developing a 'SafeBeat Kit' that combines commercially available products like mobile ECG devices, mobile cardiac telemetry, and wearable defibrillators with their proprietary software.

Products by SafeBeat Rx

1 product in the directory

SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.

Videos

News, demos, and interviews about SafeBeat Rx.

Loading videos...

Videos load interactively. If none appear, search YouTube for SafeBeat Rx →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

SafeBeat Rx is a digital health company that utilizes an AI-powered ECG platform to go beyond diagnostics and guide cardiac therapeutics. It aims to expand access to remote therapeutic monitoring for atrial fibrillation (AFib) patients, enabling them to safely initiate and manage antiarrhythmic medications from home, thereby reducing the need for hospitalization. The platform also addresses concerns about drug-induced QT prolongation, a key safety issue for many medications, by providing beat-by-beat ECG analysis with explainable AI.
SafeBeat Rx integrates with third-party FDA-cleared cardiac monitoring devices, including mobile ECGs, mobile cardiac telemetry, and implantable cardiac monitors, to enable comprehensive remote patient monitoring. Its AI-based software analyzes ECG data to provide diagnostic information and treatment recommendations, streamlining workflows for clinicians and allowing for remote titration and long-term monitoring of cardiac medications. This approach aims to replace traditional inpatient monitoring with a safe, at-home solution.
SafeBeat Rx's AI-based ECG analysis software is currently for investigational use only, and its performance characteristics have not yet been established. The company has submitted an FDA 510(k) application for approval of its QTc algorithm, which is currently underway.
SafeBeat Rx is designed for clinicians by clinicians, with software streamlined for mobile phone use that provides explainable AI and custom tools for diagnostic information and patient-specific treatment steps. The company has received support from organizations like the Heart Rhythm Society and has ongoing collaborations, including a clinical study at the University of California, San Francisco (UCSF) to validate its AI-based ECG analysis software. SafeBeat Rx also partners with manufacturers of FDA-approved wearable cardioverter defibrillators and insurers, aiming to reduce healthcare costs.
SafeBeat Rx was founded in 2020 and has a team of 1-10 employees. It has received funding from investors such as Y Combinator, HeartX Accelerator, Defense TechConnect, MedTech Innovator, LG Nova, and Zillionize. The company has also been awarded a Direct to Phase II Small Business Innovation Research (SBIR) grant of approximately $2M from the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH).

Related Companies

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

Medtronic is a global leader in healthcare technology, developing and manufacturing a vast array of medical devices and therapies. The company’s mission is to alleviate pain, restore health, and extend life for people with chronic conditions worldwide. Medtronic operates in over 150 countries, offering solutions across four main business units: Cardiovascular, Neuroscience, Medical Surgical, and […]

Philips Medical Systems Nederland B.V. is a key entity within Royal Philips, a leading global health technology company. The company focuses on improving people’s health and well-being through meaningful innovation, leveraging advanced technology and deep clinical and consumer insights to deliver integrated solutions. [6, 29] For physicians, this translates into a commitment to developing AI-enabled […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.